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Urea, Creatinine, and Glucose Determined in Plasma and Whole Blood by a Differential pH Technique
We previously described (1,2) a new instrument, based on the differential measurement of pH, and illustrated its application by the determination of glucose in plasma. We believe that this pH technique can find interesting applications in clinical chemistry. Indeed, the two more interesting advantages are that (a) the system automatically performs a sample blank and (b) turbid solutions can be analyzed directly. Moreover, many reactions lead to a change of pH in the solution. The most relevant among them are: the oxidoreductase-catalyzed reactions involving NAD/NADH or NADP/NADPH interconversion; the reactions involving transfer of phosphate residue; reactions producing CO2 and NH3; and reactions involving ester bond synthesis or cleavage. Clearly, a potentially wide range of analytes and enzyme activities can be detected by this technique. We now describe our further refinement of the technique and its extension to determination of urea, creatinine, and glucose in plasma and whole blood. 
Materials and Methods

Instrumentation.
pH was measured with a commercially available differential pH analyzer (Delpas CL; Kontron AG, Milan, Italy), an instrument similar in design to the homemade instrument we previously described (2). Improved features consist of a thermostated stainless-steel block to ensure a better temperature control of the two electrodes, a 16-character alphanumeric display, a printer, and a keyboard for parameter entry and instrument control. All measurements here reported were obtained by use of this apparatus at 23 #{176}C except for creatinine, which was measured at 37 #{176}C. An IL919 analyzer (Instrumentation Laboratory, Milan, Italy) and IL-associated chemical procedures were used as comparison methods for the determination of urea and creatinine. Computations were performed by an Altos ACS 8000/2 (Altos Computer Systems, Cuppertino, CA). The software was written in PASCAL high-level language.
Chemicals and solutions.
Lyophilized jack-bean urease (EC 3.5.1.5) was from Ames/Miles (Milan). A solution of it was prepared by dissolving a suitable amount in 10 mL of 0.1 mol/L KC1 and adjusting the pH to 7.50 with 0.1 mol/L K2C03; 15 mL of glycerol was added as a stabilizing agent. The final activity was 1440 kUIL. For each urea determination, we routinely used 11.2 U of urease. Typically, the measurement was taken 20 s after the enzyme was added. No significant loss of urease activity in solution was detected after six months at 4 #{176}C, but a 12% loss of activity was observed after four days at room temperature.
Creatinine (99% pure) and creatinine iminohydrolase (EC 3.5.4.21, microbial source) were from Farmitalia Carlo Erba, Milan. The enzyme suspension was dialyzed against 0.1 molIL KC1 solution containing NaN3, 1 g/L. The pH was then adjusted to 7.54 with 10 mmolIL NaOH, with continu- ous stirring. This enzyme solution was kept at 4#{176}C. A total of 0.4 U was used for each creatinine measurement. The enzyme can be stored for more than six months at 4#{176}C, and it loses less than 1% of activity after three days at room temperature.
Acetazolamide was kindly supplied by Wassermann (Milan, Italy). Sterox SE and urea were from Baker Chemicals (Milan) and Brij 35 from Merck. All other reagents were analytical grade.
The standard (i.e., routine) buffer used for the urea determinations had the following composition per liter: 13 mmol of Tris, 13 mmol of K2HPO4, 0.1 mol of KC1, 1 g of NaN3, 0.1 g of acetazolamide,
1.0 g of Brij surfactant, and 1 mL of Sterox SE surfactant; its pH was 7.5 at 25#{176}C. The buffer capacity of this solution is constant to within 1% in the range pH 7.5 ± 0.3. We prepared urea standard solutions by diluting a urea stock with a 0.1 mollL solution of KC1 containing 1 g of NaN3 per liter, and stored these in dark bottles at room temperature. No significant change in theirurea concentration was detected after a month's storage.
The creatinine working buffer (pH 7.54 at 25 #{176}C) contained, per liter, 5 mmol of K2HPO4, 5 mmol of Na4P2O7, 0.1 mol of KC1, 1 g of NaN3, and 1 g of Sterox SE. Creatinine standard solutions were similarly prepared by diluting a 0.1 mol/L creatinine stock solution containing 0.1 mol of KC1 and 1 g of NaN3 per liter. A 113 mgfL creatinine standard was used as calibrator.
The creatinine comparison method is based on the reaction of creatinine with picric acid in alkaline solution, and it is improved by the high concentration of the anionic surfactant and by use of the kinetic mode. The comparison method for urea involves the urease/glutamate dehydrogenase reactions. All comparison determinations were made in an 1L919 analyzer, by the supplier-recommended procedures. Glucose was determined with the pH apparatus as previously described (1).
Sample collection. To normal and pathological blood specimens we added EDTA and NaF, each 1 g/L final concentration, as anticoagulants.
Serum and blood samples with high creatinine concentrations were obtained from our Hemodialysis Department. Control lyophilized sera ("Precinorm" and "Precipath") were from Boehringer Biochemia (Milan).
Results and Discussion
Determination of Urea
When urease isadded to a urea-containing solution, the following reactions occur: The second ionization step of carbonic acid (reaction 3) can be neglected at pH 7.5. Each mole of urea thus produces about 2 mol of hydroxyl ionsin reactions 2 and 3. On taking into account the aciddissociation constant of reactions 2 and 3 and applying the law of mass conservation, it can be calculated that at pH 7.5, at final equilibrium, each mole of urea produces 1.05 mol of OH. This causes an increase in the pH of the solution, which is measured with the pH apparatus. The correlation between results by the pH method and the 1L919 method of urea determination can be estimated from the data reported in Figure 2A . The solid line corresponds to the equation y = 0.99x -4.01 (n = 40, r = 0.992). Table 1 shows the analytical recovery by the ipH method when plasma or whole blood was enriched by addition of urea standard solutions. The data under the "Found" column were calculated taking into account the increase in the -. 
mg/dL), bilirubin (8 mg/dL), creatinine (5 mg/dL), fructose (500 mg/dL), glucose (500 mg/dL), hemoglobin (2 g/L), 2-oxoglutaric acid (1 mmol/L), pyruvic acid (5 mmol/L), salicylic acid (20 mg/dL), triglycerides (400 mg/dL), uric acid (10 mg/dL), sodium citrate (5 mg/dL), disodium EDTA (1 g/L), lithium heparin (1 g/L), and sodium fluoride (1 g/L). None interfered significantly.
Determination of Creatinine
Determination of creatimne by the pH method is based on the following reactions: Table 1 reports the analytical recovery for a plasma and a blood sample progressively enriched by addition of standard aqueous creatinine solutions.
To examine interference with the creatinine measurements we used the same substances as for urea, the only differences being in the concentrations of some of them: bilirubin (24 mg/dL), triglycerides (500 mg/dL), and urea (200 mg/dL). As was true for urea, none interfered significantly, confirming the high degree of specificity of the creatinine iminohydrolase (3).
Determination of Urea, Creatinine, and Glucose in Plasma and Whole Blood
We estimated urea concentrations in whole blood and plasma of 75 blood samples. Each sample was divided into two parts; one was kept on ice, the second was centrifuged at 4 #{176}C to separate plasma. Determinations were made for each successive sample alternately on whole blood and plasma. Creatinine in whole blood and plasma was estimated by the same procedure as described for urea.
Linearity, precision, and accuracy for glucose determinations in aqueous solutions and in plasma have already been defined (2) . We have extended our previous study to the determination of glucose in whole-blood samples by the method previously developed (2) for plasma. Precision was evaluated as for urea and creatinine determinations.
The following results were obtained for a set of 10 measurements made on each of two blood samples,one from a normal subject and the other from a diabetic. The mean glucose concentrations were, respectively, 81 mg/dL (SD 1.9%) and 253 mg/dL (SD 1.1%). Table 1 shows the results of glucose recovery tests. Table 2 shows the values we obtained for urea, glucose, and creatimne in whole blood sampled from 19 fasting healthy individuals, as determined by the pH method. Figure 3 (A, B, and C) 'shows results of determinations of urea (n = 75), creatinine (n = 66), and glucose (n = 70) by the ipH method in plasma and whole blood. Each point refers to the determination of the respective analyte in the same sample.
The main limitation in use of the pH technique for whole blood is the high buffering capacity of the sample. We have shown that when a volume (V8)ofsample with a total buffer capacity (I3) is introduced into a buffer whose volume is Vb and buffer capacity (3b the total buffer capacity (13) of the resulting mixture is given by
With the buffer composition used in this study, it can be calculated that the contribution of a 10-tL plasma sample to the total buffer capacity is 0.7% for glucose and 0.3% for urea-clearly negligible for all practical purposes. Otherwise, if a blood sample is analyzed, one must take into account the blood buffering capacity of the sample, which can be expressed as
where p is the buffer power of the C02-bicarbonate system, 13r'nps is the buffer value of the non-bicarbonate plasma The buffer power of the non-bicarbonate plasma buffers, assuming that the titration curve of plasma proteins is linearin the pH range 7.3-7.6, is equal to:
where Vc is the fractional erythrocyte volume and [Pri is the total protein plasma concentration in grams per liter.
The hemoglobin buffer value, as oxyhemoglobin, in the pH range 7.3-7.6, can be calculated from the data of In the case of the creatinine assay the blood buffer capacity significantly affects the measurement, by about 10.9% for plasma and 33% for blood samples. Because normal creatinine concentrations in blood are in the range 0.05 to 0.1 mmol/L-i.e., about /79 those for glucose and urea, we lowered the buffer capacity of our standard buffer and used a sample volume fivefold that used for glucose or urea determinations, so as to achieve the required sensitivity inthe measurements.
Under these conditions, the precisionand sensitivity of the instrument used for thiswork proved to be of the same order as that of the laboratory-(9) made apparatus we previously used (1, 2). The positive error caused by dextran in results for serum proteins by the biuret procedure may be substantial, as much as 50% in our experience, but nevertheless may escape detection during analysis involving some types of analytical equipment (1, 2). This interference reportedly occurs with some biuret reagents (1-5) but not others (1,2,  6, 7) . In view of this, and of our preliminary finding that of Biochemistry Department, Edgware General Hospital, Edgware, Middx., HA8 OAD, U.K.
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two biuret procedures studied in this laboratory only one was affected by dextran, we decided to establish reaction conditions that would be interference-free.
Materials and Methods
Patients'
samples. Serum was obtained from patients before and for as long as five days after the infusion of one or two units of dextran solution [Dextran-70, 60 g/L, in physiological saline; "Macrodex"; Pharmacia (Great Britain) Ltd., Hounslow, Middx., U.K.].
Protein
standard. Human albumin, 200 g/L, in saline solution (Kabivitrum Ltd., Uxbridge, Middx., U.K.).
Chemicals
were of"Analar" quality (BDH Chemicals Ltd., Poole, Dorset, U.K.).
Biuret reagents
used or referred to in this work were constituted as shown in Table 1 . The BDH reagents were obtained from BDH Chemicals Ltd. and the Roche reagent from Roche Diagnostics Ltd., Welwyn Garden City, Herts., U.K.
Protein assays were carried out with discrete analyzers, with the "Kem-O-Mat" (Coulter Electronics Ltd., Luton, Beds., U.K.) or the Gilford 203S (Corning Ltd., Halstead, Essex, U.K.) with use, respectively, of 15-or 10-1zL sample and 500 1iL of working biuret reagent.
Mixtures were
